What is the Optimal SpO2 Target in Vented Patients?

November 10, 2022 00:25:12
What is the Optimal SpO2 Target in Vented Patients?
Critical Care Perspectives in Emergency Medicine
What is the Optimal SpO2 Target in Vented Patients?
/

Show Notes

Approximately 3 million critically ill patients are intubated and initiated on mechanical ventilation each year in the United States. A critical component of mechanical ventilation is the adjustment of FiO2 to maintain adequate arterial oxygen saturation.  However, the optimal oxygenation target in critically ill adult patients receiving mechanical ventilation remains uncertain. In this podcast we discuss a recently published study, the PILOT Trial, that evaluated low, intermediate, and high oxygenation targets in critically ill patients.

You can get CME credit for this episode hereClick here for CME Account Creation Instructions

Other Episodes

Episode

March 25, 2017 00:17:05
Episode Cover

High Dose NTG in ACPE

ED Pharmacist extraordinaire Jill Logan joins CCPEM to discuss the use of high-dose nitroglycerin in patients with acute cardiogenic pulmonary edema.  Is it safe?  How much can, and should, you give during the initial resuscitation of these sick patients? Download Companion HandoutDownload You can get CME credit for this episode here Click here for CME Account Creation Instructions ...

Listen

Episode

September 17, 2019 00:19:53
Episode Cover

Do ED-Based ICUs Make a Difference?

Over the past decade, the annual hours of critical care delivered in US emergency departments has sharply risen. Undoubtedly, many critically ill patients remain in the ED for numerous hours awaiting an ICU bed.  In an attempt to improve the delivery of critical care to boarding ED patients, several hospitals and health care systems have recently implemented ED-based ICUs.  In this podcast, we discuss a recent article published in JAMA Open Network evaluating the impact on mortality and resource utilization of an ED-based ICU. Download Companion HandoutDownload You can get CME credit for this episode here! Click here for CME Account Creation Instructions ...

Listen

Episode

July 15, 2020 00:26:28
Episode Cover

TXA for GI Bleeds? The HALT-IT Trial

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice.  Download Companion HandoutDownload You can get CME credit for this episode here!Click here for CME Account Creation Instructions ...

Listen